Dr. Russell Petrak, managing senior partner of Metro Infusion Center, calls on Blue Cross Blue Shield to continue covering ...

A healthcare professional gives you this drug as an intravenous (IV) infusion. The infusion takes about an hour, and you typically get it every 4 weeks. Note: Natalizumab (Tysabri) has a black box ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Delivery of i.v. medications via infusion devices has traditionally not been a major concern for pharmacists. The introduction of smart infusion technology has changed that paradigm by requiring ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.